IL1B and atopic eczema: In atopic dermatitis-like skin lesions, laminarin alleviates inflammation and modulates immune responses by suppressing IgE hyperproduction, mast cell infiltration, and the release of pro-inflammatory cytokines such as IL-1β, TNF-α, MCP-1, and MIP-1α.